Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024)
Ginkgo Bioworks Holdings' (DNA) quarterly Interest Expenses came in at $31.4 million in Q4 2024, down 28.72% on a YoY basis from $44.0 million in Q1 2024, and up 439.09% quarter-over-quarter from -$9.3 million in Q3 2024.
Analysis
Ginkgo Bioworks Holdings (DNA) Interest Expenses (2020 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Interest Expenses for 4 consecutive years, with $31.4 million the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Interest Expenses fell 28.72% year-over-year to $31.4 million; the trailing twelve-month figure through Dec 2024 stood at $55.8 million (up 267.45% YoY), and the FY2024 full-year result was $94000.0, up 1.08% from the prior year.
- Interest Expenses grew to $31.4 million in Q4 2024 per DNA's latest filing, from -$9.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $44.0 million in Q4 2023 and bottomed at -$15.0 million in Q3 2023.
- Historically, Interest Expenses has averaged $2.9 million across 4 years, with a median of $570500.0 in 2020.
- The widest YoY moves for Interest Expenses: up 38.41% in 2024, down 28.72% in 2024.
- Over 4 years, Interest Expenses stood at $590000.0 in 2020, then retreated by 6.61% to $551000.0 in 2021, then jumped by 7886.75% to $44.0 million in 2023, then dropped by 28.72% to $31.4 million in 2024.
- According to Business Quant data, Interest Expenses over the past three periods registered $31.4 million, -$9.3 million, and -$10.3 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 197.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 30.34 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -48.79 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -3,647.53 |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 31.37 Mn |
| Sep 30, 2024 | -9.25 Mn |
| Jun 30, 2024 | -10.31 Mn |
| Dec 31, 2023 | 44.01 Mn |
| Sep 30, 2023 | -15.02 Mn |
| Jun 30, 2023 | -14.35 Mn |
| Dec 31, 2021 | 551,000.00 |
| Sep 30, 2021 | 649,000.00 |
| Dec 31, 2020 | 590,000.00 |
| Sep 30, 2020 | 592,000.00 |